Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/bmj.p170 | DOI Listing |
Front Med (Lausanne)
January 2025
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Introduction: The 2020 pharmaceutical strategy for Europe stressed that rethinking regulatory policies to foster innovation in disease areas with unmet medical needs (UMN) is one of the European Commission's (EC) priority areas. To understand stakeholders' views regarding appropriate UMN criteria and incentives, the EC developed a survey and launched it for public consultation between September and December 2021. This study aims to assess stakeholders' views on the policy revisions proposed by the EC, particularly those regarding the definition of UMN, its criteria and incentives and evaluate how stakeholders' views are reflected in the proposed reform of the EU pharmaceutical legislation of 2023.
View Article and Find Full Text PDFJAMA Netw Open
January 2025
Department of Medicine, University of Washington, Seattle.
Importance: For patients hospitalized with acute decompensated heart failure (ADHF), the presence of kidney dysfunction can substantially shape prognosis and treatment options. Yet little is known about the lived experiences of these medically vulnerable patients.
Objective: To elicit accounts of the illness and care experiences of patients currently or recently hospitalized with ADHF and kidney dysfunction in order to identify potential opportunities to improve care.
PLOS Glob Public Health
January 2025
African Centre of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Nigeria.
Med Teach
January 2025
Indiana University School of Medicine, Anatomy and Cell Biology.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!